What exactly does Boteng stock do?

Boteng (300363) is mainly engaged in pharmaceutical customization, R&D and production services.

Scope of business: API production (operated according to the project approved by the Pharmaceutical Production License, valid for 2065438+July15); Technical development and technical services of innovative drugs; Production and sales of pharmaceutical intermediates and fine chemicals (excluding licensed business items such as dangerous chemicals and precursor chemicals); Import and export of self-operated commodities and technologies (if the above business scope is prohibited by national laws, regulations and administrative rules, it is prohibited to engage in production and operation; if there are specific provisions in national laws, regulations and administrative rules, it is prohibited to engage in production and operation without the administrative permission of relevant departments).

Founded in July 2005, Chongqing Boteng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Boteng Shares") is headquartered in Chongqing, China, with subsidiaries in Chengdu, China, Shanghai, Yichun, Jiangxi, Hongkong, China, Belgium, Switzerland and the United States. Is a high-tech enterprise that provides customized drug R&D and production services for multinational pharmaceutical companies and biopharmaceutical companies according to international standards. Boteng shares were listed on the Growth Enterprise Market of Shenzhen Stock Exchange on129 October, 2014,65438, stock code 300363.

Boteng is the top three pharmaceutical R&D and production outsourcing organization (CDMO) in China, which is mainly committed to providing customized R&D and customized production services for pharmaceutical companies and new drug R&D organizations around the world from early clinical research to drug listing. It is the leading pharmaceutical R&D and production outsourcing organization (CDMO) in China. Headquartered in Chongqing, China, the company has subsidiaries in Chengdu, Shanghai, Yichun, Jiangxi, China, Hongkong, Belgium, Switzerland and the United States.

As one of the leading pharmaceutical customized R&D and production enterprises in China, Boteng shares have two domestic production bases in Changshou, Chongqing and Yichun, Jiangxi, and three R&D centers in Chongqing, Shanghai and Chengdu. The company has gathered a high-quality management team with an international vision, and established a good reputation in the industry by relying on its advantages in business model, R&D technology and comprehensive management. It has become a customized R&D and production service provider for the global top 65438 pharmaceutical companies 1 1.

Boteng Co., Ltd. has authorized invention patents 12 and invention patents 13 (including 2 PCT patents), and dozens of products have won national 863 plan, national key new products, national torch plan and Chongqing key new products for many times. In 20 12, the company won the global CMO (customized drug R&D and manufacturing enterprise) leader award.